INMUNOTEK is a pharmaceutical company dedicated to researching, developing, manufacturing, and distributing therapeutic vaccines for allergies, infectious diseases, and cancer. The company also produces and markets medical devices. Founded in 1992, INMUNOTEK's mission is to improve patients' quality of life and provide value to healthcare professionals by offering innovative, safe, and effective products. Our products are available in Spain and over 50 other countries worldwide through subsidiaries, sales offices, and exclusive distributors. We operate two production centers located in San Sebastián de los Reyes and Alcalá de Henares, Madrid, Spain, both of which are certified under Good Manufacturing Practice (GMP) standards. INMUNOTEK has been recognized as one of Europe’s Long-Term Growth Champions in the Financial Times ranking, a testament to our sustained growth and innovation in the healthcare sector.
Looking for a particular Inmunotek employee's phone or email?
Inmunotek Questions
The Inmunotek annual revenue was $23.3 million in 2026.
Andrés Beltrán is the CEO of Inmunotek.
249 people are employed at Inmunotek.
Inmunotek is based in Alcala De Henares, Madrid.
The NAICS codes for Inmunotek are [541, 54171, 54, 5417, 541713].
The SIC codes for Inmunotek are [873, 87].
Top Inmunotek Employees
-
Andrés Beltrán
CEO at Inmunotek
Colombia -
Nuria Sinovas
Business PMO Director at Inmunotek
Community of Madrid, Spain11 -
1
-
Alfredo Subiza
Director de operaciones at Inmunotek
Alcala de Henares, ES1 -
Paqui Poves
Director Técnico and Calidad - SSRR at Inmunotek
Torrejón de la Calzada, ES -
1
Related Companies
